decreased function of receptors increase vulnerability to tobacco addiction (Bierut et al. 2008) . The brain region primarily accountable for this may be the habenulo-interpeduncular system. Its anatomical connections allow the habenula to act as a node to link the forebrain to the midbrain regions that are involved in regulating emotional behaviors such as pain, stress, and anxiety (Hikosaka 2010) . In fact, recent observations assign a5-containing nAChRs in the habenular complex a key role in controlling nicotine consumption (Fowler et al. 2011; Frahm et al. 2011 ) and nicotine withdrawal ). a5 may require the presence of the b4 subunit, because decreased signs of nicotine withdrawal have been observed not only in mice lacking a5 but also in b4 knockout (KO) animals (Salas et al. 2004 De Biasi and Salas 2008) .
As the pharmacological and biophysical properties of a4b2* differ significantly from a3b4* receptors , knowledge of subunits that co-assemble with a5 is important for understanding the role of habenular nAChRs in nicotine abuse and dependence. We therefore reanalysed nAChRs found in the habenula of rats and mice and paid particular attention to a5-containing receptors.
Materials and methods
Generation and purification of antibodies All antibodies were targeted against the cytoplasmic loop region of mouse nAChR subunits as previously published for anti-a3, anti-a4, anti-a5, anti-b2, and anti-b4 (David et al. 2010) . The immunoprecipitation (IP) efficacy and specificity of our anti-a3, -a4, -b2, and -b4 antibodies has previously been tested with recombinant receptors expressed in HEK-293 cells, and by comparing the IP results in the SCG of a5b2 and a5b4 double KO (Kedmi et al. 2004 ) mice (which express pure a3b4 and a3b2 receptors, respectively) with polyethyleneglycol precipitation of all solubilized receptors. Furthermore, we took advantage of nAChR-KO mice to exclude false-positive reactions of our anti-a5, -b2, and -b4 antibodies ( Figure S1 , David et al. 2010) . We now probed the efficacy of the anti-a5 antibody, which was generated by immunizing rabbits with the loop region of the a5-subunit, on receptors generated by replacing the cytoplasmic loop of the b2 subunit amino acids (aa) 345-415 by the loop of a5 (aa 362-418), and by co-expression of this chimera with a4 in HEK-293 cells (see Figure S1 ).
The proteins used for immunizing rabbits against the subunits a2 and a6 consisted of maltose-binding protein, fused to loop regions covering aa 361-444 (anti-a2) and aa 359-432 (anti-a6) , respectively. The antibodies were affinity-purified using the corresponding glutathione S-transferase fusion protein coupled to Affi-Gel 10 (Bio-Rad Laboratories, Hercules, CA, USA) and probed with recombinant receptors expressed in HEK-293 cells as well as with native materials taken from the cerebellum, the C. striatum, and the interpeduncular nucleus ( Figure S1 ).
Animals and preparation of habenula
Experiments were performed on WT C57Bl/6J mice, and on mice with deletions of the nAChR subunit genes a5 (Wang et al. 2002) , b2 (Picciotto et al. 1995) , and b4 (Kedmi et al. 2004) . b2 KO mice were generously provided by J.-P. Changeux (Pasteur Institute, Paris), a5 KO and b4 KO by Avi Orr-Urtreger (Sourasky Medical Center, Tel Aviv). Mice used in this study were backcrossed into C57Bl/6J background for 6 (b4), 7 (a5) or 12 (b2) generations after germ line transmission.
Sprague-Dawley rats (Oncins France strain A) were obtained from the Institute of Biomedical Research, Medical University of Vienna (Himberg, Austria) and bred in-house. All animals were kept in thermo stable rooms (21°C) on a light-dark schedule of 10 : 14 h in group cages with food and water freely accessible. Animal care and experiments are in accordance with the European Communities Council directive (86/609/EEC) and the Austrian federal law governing animal experimentation (Tierversuchsgesetz TVG 501/ 1989) .
The great majority of experiments was performed with prepubertal mice and rats (mostly P18, range 17-19 days), killed by decapitation. Adult mice (6-8 weeks) and rats (300-600 g) were deeply anesthetized with diethylether before decapitation. We dissected entire habenulae, though hetero-pentameric nAChRs are highly enriched in the medial habenula (MHb) with only few such receptors in the lateral habenula (Clarke et al. 1985; Wada et al. 1989; Perry and Kellar 1995; Le Novere et al. 1996; Perry et al. 2002; Whiteaker et al. 2002) . Habenulae were collected in Ca 2+ -free Tyrode's solution: 150 mM NaCl, 4 mM KCl, 2.0 mM MgCl 2 , 10 mM glucose, and 10 mM HEPES, pH 7.4. After removal of the Tyrode's solution, tissue was flash-frozen with liquid nitrogen and stored at -80°C for later use.
Immunoprecipitation of [ 3 H]-epibatidine labeled receptors
Receptors were solubilized in 2% Triton X-100 lysis buffer: 50 mM Tris-HCl pH = 7.5, 150 mM NaCl, 2% Triton X-100, supplemented with one complete mini protease inhibitor cocktail tablet (Roche Molecular Biochemicals, Indianapolis, IN, USA) per 10 mL buffer. Following one ultrasound pulse of 5 s duration at 30% energy level, samples were left for 2 hours at 4°C and thereafter centrifuged at 16 000 g for 15 min at 4°C. 130 lL clear supernatant from 0.5 habenulae (rat), 1.5 habenulae (WT, b2 KO), or 4 habenulae (b4 KO), respectively, were incubated with 20 lL 10 nM [ 3 H]-epibatidine and 7 lg antibody in 30 lL phosphate-buffered saline (10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 2.7 mM KCl, 140 mM NaCl, pH = 7.4) on a shaking platform at 4°C over night. Non-specific binding was determined by adding 300 lM nicotine to half of the samples.
Heat-killed, formalin-fixed Staphylococcus aureus cells carrying protein A (Standardized Pansorbin-cells; Calbiochem, San Diego, CA, USA) were centrifuged at 2300 g for 5 min at 4°C. Pansorbinpellets were washed twice with IP-High (50 mM Tris-HCl pH = 8.3, 600 mM NaCl, 1 mM EDTA, 0.5% Triton X-100), once in IP-Low (50 mM Tris-HCl pH = 8.0, 150 mM NaCl, 1 mM EDTA, 0.2% Triton X-100), and re-suspended with IP-Low. Twenty microliters of this suspension of Pansorbin cells were added to the above-mentioned cocktail containing the antibody, solubilized receptors, and [ 3 H]-epibatidine for 2 h at 4°C on a shaking platform. Samples were centrifuged at 2300 g for 5 min at 4°C and washed twice with IP-High and once with IP-Low at 2300 g for 1 min at 4°C. Pellets were re-suspended in 200 lL 1 M NaOH and subjected to liquid scintillation counting. For sequential immunoprecipitation (IP) experiments, the supernatant was saved, and precipitated with a second antibody as described above.
Quantification of protein contents in membrane preparations and lysates
All protein quantifications were performed using the BCA Protein Assay Reagent Kit (Pierce, Rockford, IL, USA) following the manufacturer's instructions.
Reagents
General chemical reagents were from Merck-VWR-Jencons, Radnor, PA. Substances not explicitly mentioned were from Sigma-Aldrich (St Louis, MO, USA).
Data analysis
All data are presented as means ± SEM. Statistical analyses was performed with GraphPad Prism version 4.0 (GraphPad Software Inc., San Diego, CA, USA). Student's t-test or one-way analysis of variance (ANOVA), followed by Bonferroni's multiple comparison test, were performed when appropriate.
Results
Antibodies for IP assays Subunit-specific antibodies are essential pre-requisites for the analysis of the subunit composition of nAChR subtypes. The generation of antibodies directed against the subunits a3, a4, a5, b2 and b4 has been described in our previous publication (David et al. 2010) . Anti-a2 and anti-a6 antibodies were newly generated. For a detailed characterization of antibodies, see the Methods section, Figure S1 , and supplemental Materials provided in David et al. (2010) . nAChRs in the mouse and rat habenula have similar subunit profiles We assess the overall number of [ 3 H]-epibatidine binding sites by the combined use of anti-b2 plus anti-b4 antibodies (David et al. 2010) . Hence, IPs with a combination of the two antibodies will show 100% of heteropentameric receptors. We found the overall number of receptors was similar in P18 mice and rats (301.3 ± 18.4 fmol/mg lysate protein in mice, n = 13; 252.8 ± 32.7 fmol/mg lysate protein in rats, n = 3, Fig. 1 ). In addition, the subunit profiles of nAChRs in the habenula of WT mice and rats are very much alike (Fig. 1) .
The majority of receptors of both species contain the subunits a3 (84% in mouse and 80% in rat) and/or b4 (82% of nAChRs in mouse and 72% in rat, Fig. 1 ). In either rats or mice, 33-45% of receptors contain the subunits a4 and/or b2 ( Fig. 1 ). Given that more b2 than b4-containing receptors were found in the adult rodent habenula in a previous publication (Grady et al. 2009 ) we checked in mice whether the b2/b4 proportion might be developmentally regulated. In fact, when the numbers of b2were compared with b4containing receptors in one and the same assay, their rate of occurrence increased from 0.58 ± 0.03 (means ± SEM, n = 22 assays) in P18 mice to 0.88 ± 0.06 (means ± SEM, n = 6 assays) at 6-8 weeks old animals (significantly different p < 0.01, Student's t-test). Hence, we find that b4-containing receptors outnumbered b2 not only in P18 but also in adult mice.
A small percentage of receptors include the accessory subunit a5 (6% in mouse and 2.5% in rat, both values significantly different from zero, p < 0.01 for rats and p < 0.001 for mice, one sample Student's t-test; and both values significantly differ from each other, p < 0.05, oneway ANOVA followed by Bonferroni's post hoc multiple comparison test). Again, significantly higher levels of a5containing receptors (about 27% of overall) have been reported particularly in the adult rat by Grady et al. (2009) . When analysing the number of a5-containing receptors in adult rats we found a moderate increase from 2.50 ± 0.34% at P18 (means ± SEM, n = 3 assays) to 3.25 ± 0.11% (n = 7 assays) of overall receptors in adult rats (significantly different p < 0.05, Student's t-test). We did not detect measurable amounts of the subunits a2 and a6 in either species (levels not significantly different from zero, p > 0.05, n = 3, one sample Student's t-test; Fig. 1 ).
Most receptors in the mouse habenula consist of a3b4* We used sequential IP to assess the association of the subunits a3 and b4 in WT mice. In this set of experiments, our anti-a3 antibody precipitated 269.2 ± 28.3 fmol/mg [ 3 H]-epibatidine-labelled receptors (n = 5, Fig. 2 ). When tissue extracts were first cleared with anti-b4 (the 'clearing' antibody, see Mao et al. 2008) , the number of receptors precipitated from the residual supernatant with anti-a3 (as 'capturing' antibody) was significantly (p < 0.001, paired Student's t-test) reduced to low but still measurable levels (15.9 ± 4.4 fmol/mg, n = 5, significantly different from zero, p < 0.05, one sample Student's t-test, Fig. 2 ), suggesting that a small number of a3-containing receptors occur without b4. In fact, levels of a3 significantly exceeded b4 by 40.0 ± 9.7 fmol/mg (paired Student's t-test, p < 0.01, n = 10) when a3and b4-containing receptors were determined in one IP experiment, again suggesting that in the P18 WT mouse habenula, a3-containing receptors occur without b4.
In contrast, the anti-b4 antibody precipitated 234.3 ± 29.8 fmol/mg [ 3 H]-epibatidine without pre-clearing, but only 5.8 ± 4.9 fmol/mg [ 3 H]-epibatidine after clearing with anti-a3 (n = 5, value not significantly different from zero, p > 0.05, one sample Student's t-test, Fig. 2 ). These observations suggest that the great majority of receptors are of the a3b4* type but that a small number of a3b2* receptors exist as well. a3b2 receptors in the medial habenula have previously been shown with [ 125 I]a-conotoxin MII autoradiography (Whiteaker et al. 2002) .
A significant number of receptors in the mouse habenula contain both b2 and b4 subunits A significant number of receptors in the P18 mouse habenula appears to contain both b2 and b4 subunits, because the algebraic sum of receptors precipitated by either anti-b2 or anti-b4 antibodies significantly exceeds 100% (by 18% or 56 fmol/mg, n = 11, paired Student's t-test, p < 0.001). This finding is supported by the observation that after pre-clearing with anti-b4, b2 levels are reduced by 65.7 ± 2.9 fmol/mg (n = 3, Fig. 2f ). In contrast, b4 levels are reduced by 108.2 ± 4.9 fmol/mg after pre-clearing with anti-b2 (n = 3, Fig. 2e ).
a5-containing receptors include the subunits b2 and b4
We next investigated the possible association of the a5 subunit with the subunits b2 and b4 by sequential IP. As shown in Fig. 2c , the anti-a5 antibody precipitated 21.5 ± 5.4 fmol/mg [ 3 H]-epibatidine-labeled receptors. Upon pre-clearing extracts with anti-b4 in paired experiments, the receptors precipitated with anti-a5 dropped to levels not significantly different from zero (2.1 ± 1.3 fmol/ mg, n = 5, p > 0.05, one sample Student's t-test). Likewise, levels of a5-containing receptors fell from 18.7 ± 5.3 fmol/ mg to 2.2 ± 3.4 fmol/mg after clearing with anti-b2, indicating an association of a5 and b2 as well (n = 5, not significantly different from zero, p > 0.05, one sample Student's t-test, Fig 2d) . As all b4 subunits co-assemble with a3 into one receptor (Fig. 2b) , these observations suggest a receptor consisting of a3a5b4b2. It should, however, be noted that any protocol that causes a reduction of a5-containing receptors that are already expressed at low levels pushes measurements to the limits of detection. Therefore these conclusions must be treated with caution. Interestingly, a5-containing receptors are unaffected in b2 null mice but are almost eliminated in the b4 KO (Fig. 3c) , showing that a5 requires the presence of b4 but not of b2 for assembly. As some a5-containing receptors remain in b4 null mice (2.0 ± 0.4 fmol/mg, n = 5, p < 0.01, one sample Student's t-test, significantly different from zero; Fig. 3c ) a few receptors may assemble from just a3, a5, and b2 in this Fig. 1 The overall number of nAChRs and the occurrence of distinct subunits are similar in the mouse and rat habenula. nAChRs from habenula of wild-type P18 mice (a) or P18 rats (b) were solubilized, labeled with 1 nM [ 3 H]-epibatidine and immunoprecipitated with each of the subunit-specific antibodies indicated at the abscissa. Nonspecific binding was measured in the presence of 300 lM nicotine and subtracted from the overall to obtain the specific binding shown in the figure. The mouse data represent means ± SEM of 3 (a2 and a6), 10 (a3), 7 (a4), 9 (a5), 23 (b2), or 21 (b4) independent experiments, each performed with duplicate or triplicate measurements. The rat data represent means ± SEM of three independent experiments, each performed with duplicate or triplicate measurements. The 100% values are determined by the combined use of anti-b2 plus anti-b4 antibodies, a protocol which precipitates all hetero-oligomeric receptors. NS: not significantly different from zero (p > 0.05, one sample Student's t-test).
Journal of Neurochemistry Ó 2012 International Society for Neurochemistry, J. Neurochem. (2012) 121, 551-560 Ó 2012 The Authors genotype. Still, deletion of the a5 subunit did not affect the expression of nAChRs at large or receptors containing the subunits a3, a4, b2, or b4 (Fig. 3) .
Two major entities of nAChRs in the mouse habenula: a3b4*, and a4b2*: Evidence from KO models Results from mouse models with deletions of the b2 or the b4 subunit nicely match our IP experiments with anti-b2 and anti-b4 antibodies. Whereas an IP using anti-b2 precipitates 46% of WT receptors (Fig. 1) , 36% of overall receptors are also lost in b2 null mice (Fig. 3f) . Likewise, an IP using anti-b4 precipitates 84% of receptors in WT (Fig. 1) , while 67% of overall receptors are lost in the b4 KO (Fig. 3f) . The great majority of the a3 subunit appears to co-assemble with b4, because levels of a3-containing receptors were largely reduced (by about 80%) -but not eliminated -in the b4 KO model (Fig. 3a) .
About 70% of nAChRs containing the a4 subunit are lost in the b2 KO model, indicating the extent to which a4b2 receptors are present in the WT mouse habenula (Fig. 3b ). However, about 30% of a4-containing receptors are also lost in the b4 KO, implying that some a4 normally co-assembles with b4 ( Fig. 3b ), as previously suggested by Grady et al. (2009) . We propose that the latter receptors also contain the subunit a3, because sequential IP with anti-a3 as the clearing antibody removes all b4-containing receptors in the supernatant (Fig. 2) . The combined presence of a3 and a4 in one receptor is in keeping with the observation that the algebraic sum of receptors containing the subunits a3 and a4 significantly exceeds 100% (by 20% or 56 fmol/mg lysate protein, n = 5, paired Students t-test, p < 0.05).
It is worth noting that levels of b2and b4-containing receptors are not significantly affected by deletions of the b4 and b2 subunit genes, respectively ( Fig. 3d and e ), indicating that the expression of these subunits is tightly regulated as in the mouse SCG (David et al. 2010 ).
Discussion
Soon after the identification of neuronal-type nAChRs it became clear that a fairly large variety of such receptors are expressed at a remarkable density in the habenula, a pair of small nuclei above the thalamus (Wada et al. 1989; Hill et al. 1993; Zoli et al. 1998 ). More recently, a5-containing receptors in the habenulo-interpeduncular system have attracted considerable interest due to their involvement in controlling nicotine intake (Fowler et al. 2011; Frahm et al. 2011) , in mediating nicotine withdrawal symptoms ), and in affecting anxiety-related behavior (Gangitano et al. 2009 ). The subunit composition of hetero-pentameric nAChRs in the habenula has lately been analysed in rats, in WT mice, and in mice lacking the nAChR subunits b2 and b3 (Grady et al. 2009 ). Accordingly, the authors identified receptors that contain the subunits a2, a3, a4, a5, a6, b2, b3, and b4. The accessory subunit a5 coassembled into both b2and b4-containing receptors, even though levels of a5-containing receptors were not diminished in b2 KO mice (Grady et al. 2009 accessory subunit co-assembles with b2 or b4 is of importance, because the pharmacological and biophysical properties of b2and b4-containing receptors differ significantly (Luetje and Patrick 1991; Fenster et al. 1997) . a5 furthermore affects the function of both a3b4 (Gerzanich et al. 1998; Fischer et al. 2005; Frahm et al. 2011) and b2containing (Ramirez-Latorre et al. 1996; Gerzanich et al. 1998) receptors. By re-assessing nAChRs occurring in the rodent habenula we therefore paid particular attention to a5-containing receptors and to which extent this subunit co-assembles with b2 and b4.
Our results are in keeping with previous observations that the habenula of mouse and rat is a rich source of nAChRs of great diversity. We found the overall number of heterooligomeric receptors (assessed by a combined use of b2 plus b4 antibodies), and their subunit composition is similar in rat and mice. Consistent with results by Grady et al. (2009) we precipitated receptors containing the subunits a3, a4, a5, b2, and b4. We also determined similar overall numbers of receptors in WT mice (301 versus 273 fmol/mg lysate protein by Grady et al. 2009 ), and we agree on the presence of major populations of a3b4* and a4b2*, an intermediate population of a3a4b4, and a minor population of a3b2 receptors. We were, however, unable to detect in P18 animals the low levels of a2 (2%) or a6 (3%) reported by Grady et al. (2009) in adult mice. Our sequential IPs indicate that all b4 co-assembles with a3, making a3b4* (about 85%) the most abundant nAChRs in the mouse habenula. In contrast, the data by Grady et al. (2009) suggest that b2-containing receptors (66%) outnumber b4-containing receptors (34%) in the adult mouse habenula. As we mostly used pre-pubertal animals, this discrepancy might be due to the age of the animals. However, we found more b4than b2-containing receptors in adult mice as well, even though the frequency of b2 relative to b4-containing receptors increased by the age of the animals.
Previous observations in the rat MHb by autoradiography with [ 125 I]-epibatidine in the presence or absence of ligands that block binding to a4b2 or a3b2 receptors estimated that a3b4-like binding accounts for > 85% of receptors, even though the authors caution that this value is almost certainly too high (Perry et al. 2002) . In separate binding experiments using homogenates, Perry et al. (2002) Fig. 3 Levels of nAChR in habenulae of wild-type and indicated null mice. nAChRs from habenula of wild-type mice and of mice lacking distinct nAChR subunit genes (indicated at the abscissa) were solubilized, labeled with 1 nM [ 3 H]-epibatidine and immunoprecipitated with the subunit-specific antibodies against a3 (a), a4 (b), a5 (c), b2 (d), or b4 (e). The total number of receptors in panel (f) was judged by a combined precipitation of anti-b2 and anti-b4 antibodies for WT and a5-KO mice, and by precipitation with anti-b4 and anti-b2 antibodies in b2-KO and b4-KO mice, respectively. Non-specific binding was measured in the presence of 300 lM nicotine and subtracted from the overall to obtain the specific binding shown in the figure. Data are means ± SEM of 3-6 (KO) or 6-22 (WT) independent experiments, each performed with triplicate measurements. Column data were compared using one-way ANOVA followed by Bonferroni's post hoc multiple comparison test. Significantly different from WT with *p < 0.05, **p < 0.005, ***p < 0.001. n. (Perry and Kellar 1995) . Because of its high affinity for most nAChRs, radiolabeled epibatidine has proven particularly useful for receptor autoradiography (see Perry and Kellar 1995; Zoli et al. 1998; Sharples et al. 2000; Whiteaker et al. 2000 Whiteaker et al. , 2002 Baddick and Marks 2011) . Cytisine, on the other hand, has a higher affinity for a4b2compared with a3b4-receptors and has been used at low concentrations to mask a4b2containing receptors in epibatidine receptor autoradiography (see Perry et al. 2002; Baddick and Marks 2011) . Based on quantitative autoradiography, Zoli et al. (1998) also reported enriched binding of [ 3 H]-epibatidine contrasting with much lower signals by both [ 3 H]-nicotine and [ 3 H]cytisine in the mouse MHb. As [ 3 H]-epibatidine binding was not reduced in b2 KO animals the authors conclude that 'the vast majority of binding in this area consists of receptors that do not contain the b2 subunit' (Zoli et al. 1998) . Still, binding of [ 3 H]-cytisine was diminished by > 50% in the MHb (medial part) in b2 KO mice. Furthermore, binding of [ 125 I]epibatidine measured autoradiographically in the MHb was unaffected not only in b2 but also in b4 KO mice (Baddick and Marks 2011) , suggesting that autoradiography with radiolabeled epibatidine (in the absence of additional ligands) may not detect even significant losses (see our Fig. 3f and supplemental Table 3 by Grady et al. 2009 ) of overall nAChRs in the MHb of KO animals. Conversely, autoradiography with radiolabeled epibatidine in the presence of cytisine or A-85380 (a protocol which predominantly unveils b4-containing receptors, Perry and Kellar 1995; Perry et al. 2002; Whiteaker et al. 2000 Whiteaker et al. , 2002 Baddick and Marks 2011) , shows significantly reduced binding in animals devoid of a3 (by 95%, Whiteaker et al. 2002) or b4 (by more than 75%, Baddick and Marks 2011) . Although the experiments with KO animals conducted by Baddick and Marks (2011) demonstrate that both b2 and b4 are prominently expressed in the mouse MHb, they do not provide quantitative data on the presence of b4-relative to b2-containing receptors.
Functional experiments demonstrate that both b2and b4containing receptors are expressed in the habenula of rats and/or mice. Hence, patch clamp recordings from slices of the mouse ventromedial habenula show amplitudes of currents induced by 10 lM nicotine, 1,1-dimethyl-4-phenylpiperazinium, or cytisine in MHb neurons that do not differ between WT and b2 KO animals (Zoli et al. 1998) . The moderate potency of the b2-preferring antagonist dihydro-berythroidine (Mulle et al. 1991) , the pronounced inhibition by the a3b4-selective antagonist a-conotoxin AuIB in inhibiting nicotine-induced currents, and the relative potency and efficacy of cytisine (Quick et al. 1999 ) furthermore indicate the presence of a3b4-type somatic membrane receptors in acutely dissociated habenular neurons of the rat.
However, the acetylcholine-induced 86 Rb + efflux from mouse habenular synaptosomes is almost eliminated in b2 KO animals, suggesting that all pre-synaptic receptors contain the subunit b2 (Grady et al. 2009 ). Yet, whether b2or b4 receptors make up the majority of the receptors in the rodent habenula cannot be deduced from these functional experiments. Taken together, with the exception of Grady et al. (2009) , none of the above mentioned reports are in conflict, and some are in keeping with our own observation that the majority of receptors in the MHb contain the subunits a3 and b4.
Receptors that contain the accessory subunit a5 rely on the presence of b4 for assembly in the habenula, as shown by our observation that the great majority of a5-containing receptors are lost in b4 null animals. However, our sequential IPs suggest that b2 is also an integral part of a5-containing receptors. The existence of a3a5b4b2 receptors is in keeping with observations by Grady et al. (2009) who reported that in rats, immunodepletion with a b2-specific antibody significantly reduced the level of a5-containing receptors. We can also confirm the findings in this report that the number of a5-containing receptors is unaffected in b2 KO mice. Interestingly, 86 Rb + efflux from habenular synaptosomes induced by acetylcholine is largely reduced not only in b2 KO (Grady et al. 2009 ) but also in a5-KO mice (Fowler et al. 2011 ), suggesting receptors that contain both subunits. Still, the great majority of a3b4* receptors do not contain a5, and deletion of the a5 subunit gene does not affect the expression levels of either a3 or b4. Figure 4 illustrates nAChRs occurring in the habenula of mice as deduced from the data shown in Figs 1 and 2.
With 6% in P18 mice and 2.5% in P18 rats, a5-containing receptors comprise only a small fraction of overall receptors in the habenula. These levels are significantly lower than has previously been reported (8.5% in mice; 27.6% in rats, Grady et al. 2009 ) which suggests either a developmental regulation, that the efficacy of our anti-a5 antibody is too low, or that the IPs by Grady et al. (2009) detect an undue high number of a5-containing receptors. To address the first alternative we investigated the expression of a5-containing receptors in adult rats but found only a moderate increase (from 2.5% to 3.2% of overall receptors). In order to check the efficacy of our anti-a5 antibody we created a chimera where the cytoplasmic loop of the b2 subunit was replaced by the corresponding region of a5 (see Materials and methods). When expressed together with a4, the resulting receptors were precipitated equally well with both our anti-a5 and anti-a4 antibody, suggesting that the anti-a5 antibody has an efficiency > 90% ( Figure S1 ). In native tissue, our antibody precipitated 24% and 20% a5-containing receptors in the mouse (David et al. 2010 ) and rat SCG (P. Scholze, unpublished observation), respectively. These data are in general agreement with observations by Mao et al. (2006) who reported 25-30% of a5-containing receptors in the rat SCG.
a5-containing receptors are important players in controlling addictive Fowler et al. 2011; Frahm et al. 2011) as well as anxiety-related behavior (Gangitano et al. 2009 ). The altered anxiety-related response in mice lacking the b4 subunit (Salas et al. 2003) might therefore be due to missing a3b4* receptors which contain a5 as well. How these receptors mediate the behavioral effects is unclear at present. Single-cell RT-PCR suggests that the a3, a5, b2, and b4 subunits may be present in all cultured rat habenular neurons (Sheffield et al. 2000) . These observations do not point at a particular cell type where somatic a3a5b4b2 receptors are concentrated to serve a specific function.
Alternatively, a5-containing receptors might preferentially be targeted to distinct axonal projections. Neurons in the MHb are cholinergic (Grady et al. 2009 ), glutamatergic (McGehee et al. 1995 Girod et al. 2000) , or even both cholinergic and glutamatergic (Ren et al. 2011) and mainly project to the interpeduncular nucleus (Hikosaka 2010) . Aversive high doses of nicotine activated the interpeduncular nucleus (IPN) in mice, reflected by increased Fos immunoreactivity (Fowler et al. 2011) . This effect was almost completely abolished in a5 knockout mice, suggesting that a5-containing receptors support glutamatergic transmission in the IPN under these conditions (Fowler et al. 2011 ). However, nicotine applications facilitated the frequency of glutamatergic miniature excitatory post-synaptic potentials recorded from chick IPN neurons (co-cultured with explants of the habenula) if treated with a5-antisense-oligonucleotides (Girod et al. 2000) . Recent experimental evidence furthermore suggests that the function of a3b4 receptors is reduced by the presence of a5 (and even more by its D397R variant, Frahm et al. 2011) . These data are in line with our previous observations in mouse SCG neurons that deletion of a5 greatly enhances the outflow of [ 3 H]-norepinephrine in response to pre-synaptic nAChR activation (Fischer et al. 2005) . It is worth mentioning that ACh-induced release of [ 3 H]-ACh from IPN synaptosomes is unaltered in a5 null mice, suggesting that a5-containing receptors may not reside on cholinergic axons that innervate the IPN (Grady et al. 2009 ).
To conclude, we have re-investigated the subunit compositions of hetero-oligomeric nAChRs in the habenula of mice and rats. We found that b4clearly outnumbers b2-containing receptors and that although a5 requires the presence of b4 (but not b2) it assembles into a nAChR containing a3b4 as well as b2 in the mouse habenula. Our results explain previous observations that nicotine withdrawal symptoms are abolished both in a5 and b4 KO mice (Salas et al. 2004 . Considering our observations it will also be interesting to see whether a loss of control in nicotine consumption occurs not only upon deletion of the a5 (Fowler et al. 2011) but also of the b4 subunit gene. Gene association studies have linked nicotine abuse to gene variants of the CHRNA5/ CHRNA3 gene cluster on chromosome 15 (Berrettini et al. 2008; Bierut et al. 2008) . Hence, despite their rare occurrence, the a3a5b2b4 receptor may play a key role in controlling nicotine dependence.
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